IPOs and Secondaries

IPOs and Secondaries Articles

Outdoor and recreation products company Yeti intends to price 20 million shares for an initial public offering valued up to $483 million.
Medical technology company Axonics Modulation Technologies is offering more than 6 million shares in an initial public offering valued up to more than $122 million.
Five firms plan to complete IPOs in the coming week, raising a total of nearly $1.7 billion. The week's dominant offer comes from a Brazilian payment processing firm seeking to raise $1 billion.
Genome editing company LogicBio Therapeutics expects to price more than 5 million shares for an initial public offering valued up to almost $93 million.
IT infrastructure management software provider SolarWinds now intends to list 25 million shares in an initial public offering valued up to $460 million.
Synthetic biology company Twist Bioscience expects to price 5 million shares for an initial public offering valued up to more than $103 million.
China's ownership of U.S. Treasuries falls to the lowest level in over a year, Uber could be valued at $120 billion in an IPO, and other important business headlines.
Outdoor and recreation products maker Yeti intends to price 20 million shares for an initial public offering valued up to about $483 million.
Among the effects of the alleged murder of Jamal Khashoggi by the Saudi Arabian government is the damage it will do to an IPO planned for Saudi Aramco.
There are 8 firms planning IPOs for the coming week, including $750+ million offering from a firm that makes IT infrastructure management software and a China-based maker of battery-powered scooters.
Livent shares disappointed investors when they entered the market on Thursday. The stock entered the market below the expected price range has only dropped lower as the day has gone on.
Connected planning pioneer Anaplan expects to price 15 million shares for an initial public offering valued up to about $303 million.
Lithium producer Livent intends to price 20 million shares in an initial public offering valued up to $460 million.
Aurora Cannabis, one of the world's largest and leading cannabis companies, has filed with the SEC in preparation for its initial public offering.
Biopharmaceutical company Orchard RX Limited has filed with the SEC for its initial public offering.